AMELUZ Trademark

Trademark Overview

On Wednesday, December 23, 2009, a trademark application was filed for AMELUZ with the United States Patent and Trademark Office. The USPTO has given the AMELUZ trademark a serial number of 79079825. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Saturday, October 2, 2021. This trademark is owned by Biofrontera Pharma GmbH. The AMELUZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of skin cancer, the elimination of tumors of the skin or the genital organs, warts, or skin cells with neoplastic changes; pharmaceutical preparations for skin rejuvenation; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for wound healing; pharmaceutical preparations for the treatment of acne vulgaris; pharmaceutical preparations for anti-bacterial therapy; [ sanitary preparations for medical use; fungicides, herbicides; media for bacteriological cultures; ] bacteriological preparations for medical purposes; biological preparations for medical purposes, namely, skin disorders and skin cancers; biochemical preparations for medical purposes, namely, skin disorders and skin cancers; [ enzymes for medical purposes; ] ferments for pharmaceutical purposes; [ vaccines; nutritive substances for microorganisms for medical purposes; chemical preparations for sanitary purposes; ] chemical reagants for medical p...
ameluz

General Information

Serial Number79079825
Word MarkAMELUZ
Filing DateWednesday, December 23, 2009
Status706 - SECTION 71 ACCEPTED
Status DateSaturday, October 2, 2021
Registration Number3956761
Registration DateTuesday, May 10, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of skin cancer, the elimination of tumors of the skin or the genital organs, warts, or skin cells with neoplastic changes; pharmaceutical preparations for skin rejuvenation; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for wound healing; pharmaceutical preparations for the treatment of acne vulgaris; pharmaceutical preparations for anti-bacterial therapy; [ sanitary preparations for medical use; fungicides, herbicides; media for bacteriological cultures; ] bacteriological preparations for medical purposes; biological preparations for medical purposes, namely, skin disorders and skin cancers; biochemical preparations for medical purposes, namely, skin disorders and skin cancers; [ enzymes for medical purposes; ] ferments for pharmaceutical purposes; [ vaccines; nutritive substances for microorganisms for medical purposes; chemical preparations for sanitary purposes; ] chemical reagants for medical purposes; [ chemical preparations for sanitary use; ]medicines for the treatment of skin cancer, the elimination of tumors of the skin or the genital organs, warts, or skin cells with neoplastic changes; medicines for skin rejuvenation; medicines for the treatment of psoriasis; medicines for wound healing; medicines for the treatment of acne vulgaris; medicines for anti-bacterial therapy; medicated ointments and gels for the treatment of skin disorders and skin cancers
Translation of Words in MarkThe wording "AMELUZ" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 26, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiofrontera Pharma GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address51377 Leverkusen
DE
Party NameBiofrontera Pharma GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameBiofrontera Pharma GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Monday, September 19, 2022PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, August 12, 2022PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, August 12, 2022INVALIDATION PROCESSED
Thursday, June 2, 2022PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, October 2, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Saturday, October 2, 2021REGISTERED-SEC.71 ACCEPTED
Tuesday, September 28, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 6, 2021TEAS SECTION 71 RECEIVED
Sunday, May 10, 2020COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, January 9, 2020INTERNATIONAL REGISTRATION RENEWED
Saturday, June 10, 2017NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Saturday, June 10, 2017REGISTERED-SEC.71 ACCEPTED
Monday, June 5, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 12, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 26, 2017TEAS SECTION 71 RECEIVED
Tuesday, May 10, 2016COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, August 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 27, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 25, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 4, 2011FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 4, 2011FINAL DISPOSITION PROCESSED
Wednesday, August 10, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 10, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, February 22, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2011PUBLISHED FOR OPPOSITION
Saturday, February 19, 2011NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, February 3, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, February 3, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Saturday, January 15, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 14, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 11, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 10, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 10, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 24, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 24, 2010NON-FINAL ACTION E-MAILED
Tuesday, August 24, 2010NON-FINAL ACTION WRITTEN
Friday, August 20, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 20, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 20, 2010ASSIGNED TO LIE
Wednesday, August 4, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 8, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 21, 2010REFUSAL PROCESSED BY IB
Tuesday, March 30, 2010APPLICATION FILING RECEIPT MAILED
Monday, March 29, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 29, 2010REFUSAL PROCESSED BY MPU
Saturday, March 27, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 26, 2010NON-FINAL ACTION WRITTEN
Friday, March 26, 2010ASSIGNED TO EXAMINER
Friday, March 26, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 25, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

ameluz preparations skin purposes medical pharmaceutical treatment cancers disorders chemical bacteriological